BACKGROUND: Components of the insulin signaling pathway are important regulators of growth. The FOXO (forkhead box, sub-group "O") transcription factors regulate cellular processes under conditions of low levels of insulin signaling. Studies in mammalian cell culture show that activation of FOXO transcription factors causes cell death or cell cycle arrest. The Caenorhabditis elegans homologue of FOXO, Daf-16, is required for the formation of dauer larvae in response to nutritional stress. In addition, FOXO factors have been implicated in stress resistance and longevity. RESULTS: We have identified the Drosophila melanogaster homologue of FOXO (dFOXO), which is conserved in amino acid sequence compared with the mammalian FOXO homologues and Daf-16. Expression of dFOXO during early larval development causes inhibition of larval growth and alterations in feeding behavior. Inhibition of larval growth is reversible upon discontinuation of dFOXO expression. Expression of dFOXO during the third larval instar or at low levels during development leads to the generation of adults that are reduced in size. Analysis of the wings and eyes of these small flies indicates that the reduction in size is due to decreases in cell size and cell number. Overexpression of dFOXO in the developing eye leads to a characteristic phenotype with reductions in cell size and cell number. This phenotype can be rescued by co-expression of upstream insulin signaling components, dPI3K and dAkt, however, this rescue is not seen when FOXO is mutated to a constitutively active form. CONCLUSIONS: dFOXO is conserved in both sequence and regulatory mechanisms when compared with other FOXO homologues. The establishment of Drosophila as a model for the study of FOXO transcription factors should prove beneficial to determining the biological role of these signaling molecules. The alterations in larval development seen upon overexpression of dFOXO closely mimic the phenotypic effects of starvation, suggesting a role for dFOXO in the response to nutritional adversity. This work has implications in the understanding of cancer and insulin related disorders, such as diabetes and obesity.
BACKGROUND: Components of the insulin signaling pathway are important regulators of growth. The FOXO (forkhead box, sub-group "O") transcription factors regulate cellular processes under conditions of low levels of insulin signaling. Studies in mammalian cell culture show that activation of FOXO transcription factors causes cell death or cell cycle arrest. The Caenorhabditis elegans homologue of FOXO, Daf-16, is required for the formation of dauer larvae in response to nutritional stress. In addition, FOXO factors have been implicated in stress resistance and longevity. RESULTS: We have identified the Drosophila melanogaster homologue of FOXO (dFOXO), which is conserved in amino acid sequence compared with the mammalianFOXO homologues and Daf-16. Expression of dFOXO during early larval development causes inhibition of larval growth and alterations in feeding behavior. Inhibition of larval growth is reversible upon discontinuation of dFOXO expression. Expression of dFOXO during the third larval instar or at low levels during development leads to the generation of adults that are reduced in size. Analysis of the wings and eyes of these small flies indicates that the reduction in size is due to decreases in cell size and cell number. Overexpression of dFOXO in the developing eye leads to a characteristic phenotype with reductions in cell size and cell number. This phenotype can be rescued by co-expression of upstream insulin signaling components, dPI3K and dAkt, however, this rescue is not seen when FOXO is mutated to a constitutively active form. CONCLUSIONS:dFOXO is conserved in both sequence and regulatory mechanisms when compared with other FOXO homologues. The establishment of Drosophila as a model for the study of FOXO transcription factors should prove beneficial to determining the biological role of these signaling molecules. The alterations in larval development seen upon overexpression of dFOXO closely mimic the phenotypic effects of starvation, suggesting a role for dFOXO in the response to nutritional adversity. This work has implications in the understanding of cancer and insulin related disorders, such as diabetes and obesity.
The biological control of the size of an organism is one of the
most elusive concepts in biology. What mechanisms determine the
size differences between species? What genetic and environmental
factors contribute to variations of size within a species? How does
an individual regulate the size of its organs to maintain
proportion with the rest of the body? Although much remains unanswered,
it is clear that the size of an individual is directly related to
the number of cells it has, and the size of these cells [1-3]. Thus, the final
size of an organism is determined by the number of cell divisions
that occur during development, and the amount of growth these cells
undergo. When considering the size difference between two organisms,
such as a mouse and a human, it is obvious that the main cause of
the size difference is the total number of cells [2].
Intuitively, this may lead to the conclusion that the size of an organism
is related to the rate of cell proliferation during development.
However, experimental evidence shows that there are more subtle
controls involved [4,5]. For example, increasing
or decreasing cell proliferation in the Drosophila imaginal discs
does not alter the final size, but instead produces discs with either
an increased number of small cells or a decreased number of large
cells [4,5]. These studies
indicate that there must be a genetically predetermined total cell
mass and a mechanism for sensing this critical size.Studies in Drosophila demonstrate that the evolutionarily conserved
insulin signaling pathway is involved in the control of body size,
through alterations of cell size and cell number [1].
Seven Drosophila insulin-like peptides (Dilps) have been identified
that are able to promote organism growth when expressed ubiquitously
during development [6,7]. The Dilps activate
cell signaling through the Drosophila insulin receptor (dInr), a
receptor tyrosine kinase, which can promote growth when overexpressed
in the developing eye [6,8]. Loss of function mutations
in dInr are lethal during embryogenesis [8]. However,
reduction of dInr levels through combination of weak heteroallelic
mutations [9], or through partial loss
of function mutations[6], reduces growth
and leads to the development of small adults that have reduced cell size
and number. In mammals, the insulin receptor promotes signaling
through adaptor proteins, the insulin receptor substrates (IRS)
1–4, which are required to activate phosphoinositide-3-kinase (PI3K) [10,11].
PI3K is a lipid kinase that phosphorylates inositide lipids on the inner
surface of the cell membrane, leading to the activation of the serine/threonine
kinase Akt. Once activated, Akt phosphorylates many substrates that
are involved in the regulation of metabolism, cell death/survival,
and cell proliferation. Negative regulation of insulin signaling occurs
through the tumor suppressor, PTEN. PTEN removes phosphates from
inositide lipids, thus acting in opposition to PI3K. This signaling
mechanism appears to be conserved in Drosophila, and the Drosophila
homologues of IRS 1–4 (chico), PI3K (dPI3K), Akt (dAkt) and PTEN
(dPTEN) have all been individually implicated in the regulation
of cell size, and cell number [1].
Flies that are homozygous for a null mutation in chico are
smaller than normal due to a reduction in cell size and cell number [12]. Null mutations in dAkt are
lethal [13], however, rescue
of dAkt mutants through ectopic expression of dAkt during
embryogenesis results in a small fly phenotype [14] similar to that seen with chico mutants
and through reduction of dInr activity. Clearly, components of the
insulin signaling pathway act to control body and organ size through
regulation of cell size and cell number during development.In addition to developmentally predetermined size control, many
cells and organisms can alter their size according to environmental
stimuli, such as nutrient limitation. When Drosophila larvae are
raised under nutrient limited conditions the adults are smaller
than well-fed flies[15,16] This
phenomena appears to be phenocopied in the generation of small adults
through inhibition of Drosophila insulin signaling [6,9,12,14].
Interestingly, expression of Dilps 3, 5, and 7 has
been linked to the availability of nutrients [7].
These Dilps are produced in neurosecretory cells in the larval brain
where they are released into the circulatory system [7].
These studies indicate that nutritional signals may regulate body
size by modulating the levels of Dilps 3, 5, and 7 in the body.Newly hatched Drosophila larvae require a nutritional signal
to initiate the cell cycle in mitotic tissues [17]. Well-fed larvae increase their body
mass very rapidly due to replication of cells in mitotic tissues.
In contrast, larvae hatched into conditions of amino acid starvation
live in a state of developmental arrest for several days until nutrients
become available to initiate the cell cycle[16,17]. Dominant
negative inhibition of dPI3K in developing Drosophila larvae has
been shown to phenocopy the effects of amino acid starvation [18]. Expression of dPI3K in subsets of
cells in the imaginal discs of starved larvae allows these cells
to divide in the absence of nutritional signals [18]. Expression of dPI3K in the fat bodies
of starved larvae significantly reduces their survival, thus conferring
starvation sensitivity in these larvae [18].
This suggests that Drosophila insulin signaling may play a protective
role in the response to starvation.An insulin-like signaling pathway involved in the response to
nutrient limitation also exists in the nematode Caenorhabiditis
elegans. When C. elegans are raised under conditions
of nutrient limitation, they enter an alternate developmental stage
called the dauer larvae. The dauer stage is characterized by arrest
of growth at a sexually immature stage along with altered metabolism
to increase the storage of fat [19].
Mutations in components of the insulin signaling pathway in C.
elegans lead to dauer larvae formation and increased life span [20-24].
A null mutation in the C. elegans gene, Daf-16, negates
dauer formation and the life expanding effect of these mutations [21,25,26]. Thus, in C.
elegans, Daf-16 is necessary for dauer formation and seems
to be the primary effector molecule under conditions of low levels
of insulin signaling.Daf-16 is the C. elegans homologue of a highly conserved group
of Akt phosphorylatable forkhead transcription factors, the FOXO
(forkhead box, subgroup "O") transcription
factors. These transcription factors were first discovered as proto-oncogenes,
which were disrupted as a result of chromosomal translocations leading
to acute myeloid leukemia and rabdomyosarcoma[27,28].
Three versions of FOXO have been identified in humans (FOXO1, FOXO3a,
and FOXO4; formerly known as FKHR, FKHR-L1, and AFX) and mice (Foxo1,
Foxo3, and Foxo4), and additional homologues have been identified in
zebrafish and chickens[29]. The FOXO transcription factors
share a highly conserved forkhead box DNA binding domain in the
N-terminal half of the protein, and three highly conserved Akt phosphorylation
sites. Mammalian cell culture studies have shown that in the absence of
Akt signaling, FOXO is able to activate gene transcription and cause
cell death, cell cycle arrest, or cell senescence [30,31].
In the presence of activated Akt, FOXO becomes phosphorylated and
is sequestered in the cytoplasm through facilitation of 14-3-3 binding [32-35], and/or
disruption of a nuclear localization signal[34,36]. The
down-regulation of FOXO in this manner is, possibly, one of the
most important consequences of Akt mediated signaling.Based on evidence from studies in C. elegans and mammalian
cell culture, it appears that FOXO transcription factors are a critical
mediator of cellular processes under conditions of low levels of
insulin signaling. To investigate this further, we have identified
and characterized the Drosophila melanogaster version of FOXO.
We show that DrosophilaFOXO (dFOXO) retains the conserved domains seen
in other organisms and is involved in the regulation of growth.
Of special interest is that dFOXO appears to have an effect upon
feeding behavior, and may be a key player in the response of Drosophila
larvae to nutritional stress.
Results
dFOXO retains the functional domains found in Daf-16 and
the mammalian FOXO homologues
The dFOXO gene consists of 10 exons and is spread out over
approximately 31 kb in polytene chromosome section 88A within the
genomic scaffolding region, AE003703, of the Berkeley Drosophila
Genome Project (BDGP) (Figure 1A). dFOXO encodes
a theoretical protein of 463 amino acids (Figure 1B). Analysis of the
complete Drosophila genome for additional dFOXO homologues revealed
none.
Figure 1
. (A) Schematic
representation of the dFOXO cDNA clone LD05569 and its location
in the genomic scaffolding, region AE003703, of the BDGP sequence.
(B) ClustalW alignment of the proposed dFOXO amino acid sequence
with that of mammalian homologues (FOXO1a, FOXO3a, and FOXO4) and
Daf-16a1. Highlighted are: the T1, S1, and S2 Akt target sequences
(yellow shading); the potential DYRK1a/mnb phosphorylation site
(arrow, and grey shading); and the forkhead box DNA binding domain (black
box). "*" indicates nucleotides that are identical in all sequences
in the alignment, ":" indicates conserved substitutions, according
to the chemical nature of the amino acids, and "." indicates semi-conserved
substitutions. Colors indicate the chemical nature of the amino
acid; Red = small hydrophobic (including aromatic), Blue = Acidic,
Magenta = Basic, and Green = basic amino acids with hydroxyl groups
and/or amine groups.
. (A) Schematic
representation of the dFOXO cDNA clone LD05569 and its location
in the genomic scaffolding, region AE003703, of the BDGP sequence.
(B) ClustalW alignment of the proposed dFOXO amino acid sequence
with that of mammalian homologues (FOXO1a, FOXO3a, and FOXO4) and
Daf-16a1. Highlighted are: the T1, S1, and S2 Akt target sequences
(yellow shading); the potential DYRK1a/mnb phosphorylation site
(arrow, and grey shading); and the forkhead box DNA binding domain (black
box). "*" indicates nucleotides that are identical in all sequences
in the alignment, ":" indicates conserved substitutions, according
to the chemical nature of the amino acids, and "." indicates semi-conserved
substitutions. Colors indicate the chemical nature of the amino
acid; Red = small hydrophobic (including aromatic), Blue = Acidic,
Magenta = Basic, and Green = basic amino acids with hydroxyl groups
and/or amine groups.Alignment of dFOXO with the human homologues of FOXO and Daf-16a1
using ClustalW [37] (Figure 1B) revealed that although
the overall identity of amino acids is not high, the identity in
the forkhead box DNA binding domain is between 74 and 86 percent.
The Akt phosphorylation sites are also well conserved in their relative
position in the protein, and in sequence. The T1 site is located at
T24 in dFOXO, the S1 site at S160, and the S2 site at S239. These
sites align well with the humanFOXO homologues in the ClustalW
alignment, however the Daf-16 S1, and S2 sites are slightly out
of line (Fig 1B).
All three of the potential Akt phosphorylation sites in dFOXO fit
the Akt consensus target sequence (RxRxxS/T).Other notable features found in FOXO homologues include a DYRK1a
phosphorylation site, a 14-3-3 binding site, a nuclear localization
signal (NLS), a nuclear export signal (NES), and Ral dependent phosphorylation
sites. A DYRK1a phosphorylation site was confirmed experimentally
in FOXO1 at S329 [38]. This serine residue
is conserved in humanFOXO3a (S324), FOXO4 (S267), Daf-16a1 (S317),
and dFOXO (S248) (Figure 1B).
In addition, the sequence surrounding this site in dFOXO (LS248PI)
is identical to that in FOXO1. The high conservation of this sequence
indicates that dFOXO may be phosphorylated at this site by the Drosophila
homologue of DYRK1a, minibrain (mnb).Binding to 14-3-3 proteins is thought to be an important part
of FOXO sequestration [30,31].
14-3-3 proteins normally bind to a consensus site containing a phosphoserine
residue, either RSxSPxP, or RxxxSPxP [39]. In the case of dFOXO, the sequence
surrounding the T1 Akt phosphorylation site fits the former perfectly,
aside from the substitution of a threonine for a serine. It has
been shown experimentally that 14-3-3 does bind to this site in FOXO1 [40], FOXO3a [33],
and Daf-16[32], hence, it is likely
that this region functions as a 14-3-3 binding site in Drosophila.The current model for FOXO deactivation suggests that a NES exists
which causes constitutive localization of FOXO in the cytoplasm
in the absence of a functional NLS [31]. A
non-conventional NLS was identified in humanFOXO4 from amino acids
180–221 [36]. The corresponding sequence
in dFOXO (amino acids 147–194) is 38% identical and 66% similar
in amino acid content (Figure 1B). This
similarity suggests that this region may act as an NLS in dFOXO
as well. A leucine rich NES has been identified in FOXO1 (368 MENLLDNLNL 377)
and the conservation of this sequence is quite high FOXO3a, FOXO4,
and Daf-16[30] (Figure 1B). The corresponding
region in dFOXO retains two of the important leucine residues (281 LTGTMADELTL 291).
However, the remaining sequence is more divergent, and may
or may not act as an NES in Drosophila.FOXO4 has previously been shown to be phosphorylated in a Ral-dependent
manner at threonines 447 and 451[41].
However, these sites do not appear to be conserved in the other
humanFOXO homologues, Daf-16, or dFOXO (Figure 1B), indicating that
Ral dependent phosphorylation of FOXO may be specific to FOXO4.Interestingly, the carboxy-terminal three amino acids are conserved
between dFOXO and FOXO1 (VSG). Also, FOXO3a contains a similar sequence
in the final three amino acids (VPG). In view of this conservation,
it is possible that this tail plays a functional role in FOXO regulation.
dFOXO expression during development phenocopies starvation
and alters feeding behavior
Drosophila larvae feed continuously for about 5 days after egg
laying (AEL). During this time the appetite and growth rate of the
larvae is enormous. If young larvae are deprived of food, they do
not grow and tend to disperse randomly[16,17,42]. When the food
supply is replenished, the larvae immediately move towards it and
continue eating until they are close to pupation. If the food supply
is depleted, the larvae will disperse again[42].
We utilized the UAS/Gal4 ectopic expression system [43] to overexpress dFOXO in the developing
larvae under the control of the ActGal4 driver[44]. This resulted in complete developmental
arrest of the larvae, which remained as first instar for up to 7
days (Figure 2A),
similar to the life expectancy of starved larvae [16-18].
This trend was also seen using a constitutively active version of MurineFoxo1
(mFoxo1) containing an alanine substitution at the T1 (T24A), and
S1 (S253A) Akt phosphorylation sites (mFoxo1-AA) [45] (Figure 2A).
In addition, larvae expressing dFOXO and mFoxo1-AA were often found
to be wandering far from their food supply. We monitored feeding
behavior by assessing the number of larvae away from their food
at 48 and 72 hours after egg laying (AEL). Larvae expressing dFOXO
and mFoxo1-AA showed a 3–4 fold increase in wandering over larvae
expressing Gal4 alone (Figure 2B).
Thus, dFOXO expression drastically alters feeding behavior and is
able to induce a starvation type response in larvae which have an
adequate food supply.
Figure 2
Expression of dFOXO in first instar larvae phenocopies
starvation and effects feeding behavior. Expression of dFOXO
and mFOXO1-AA early in larval development using the (A) ActGal4 and
(C) hsGal4 driver lines leads to developmental arrest similar
to that seen in starved larvae. Developmentally arrested larvae
are capable of surviving for up to seven days after egg laying (AEL).
(B) Expression of dFOXO (red bars) and mFOXO1-AA (green bars) leads
to alterations in feeding behavior when compared to controls (grey
bars). The percentage of wandering larvae is significantly greater
in larvae expressing dFOXO and mFOXO1-AA at 48 hours and 72 hours
AEL (p = 0.05). Expression of dPI3K-DN (blue bars) did not increase
larval wandering. (D) Developmental arrest is reversible upon removal
of dFOXO expression (red bars), but not upon removal of mFOXO1-AA
expression (green bars). Grey bars represent the controls. Each
bar reflects the average of three separate trials, with 50 larvae
per trial. Genotypes are; (A-top, B-grey bars) w; ActGal4/+,
(A-middle, B-red bars) w; ActGal4/+; UAS-dFOXO/+, (A-bottom,
B-green bars) w, UAS-mFoxo1-AA/w; ActGal4/+, (C-top, D-grey
bars) w; hsGal4/+, (C-middle, D-red bars), w; hsGal4/UAS-dFOXO,
(C-bottom, D-green bars) w, UAS-mFoxo1-AA/w; hsGal4/+,
(B-blue bars) w; ActGal4/UAS-dPI3K-DN.
Expression of dFOXO in first instar larvae phenocopies
starvation and effects feeding behavior. Expression of dFOXO
and mFOXO1-AA early in larval development using the (A) ActGal4 and
(C) hsGal4 driver lines leads to developmental arrest similar
to that seen in starved larvae. Developmentally arrested larvae
are capable of surviving for up to seven days after egg laying (AEL).
(B) Expression of dFOXO (red bars) and mFOXO1-AA (green bars) leads
to alterations in feeding behavior when compared to controls (grey
bars). The percentage of wandering larvae is significantly greater
in larvae expressing dFOXO and mFOXO1-AA at 48 hours and 72 hours
AEL (p = 0.05). Expression of dPI3K-DN (blue bars) did not increase
larval wandering. (D) Developmental arrest is reversible upon removal
of dFOXO expression (red bars), but not upon removal of mFOXO1-AA
expression (green bars). Grey bars represent the controls. Each
bar reflects the average of three separate trials, with 50 larvae
per trial. Genotypes are; (A-top, B-grey bars) w; ActGal4/+,
(A-middle, B-red bars) w; ActGal4/+; UAS-dFOXO/+, (A-bottom,
B-green bars) w, UAS-mFoxo1-AA/w; ActGal4/+, (C-top, D-grey
bars) w; hsGal4/+, (C-middle, D-red bars), w; hsGal4/UAS-dFOXO,
(C-bottom, D-green bars) w, UAS-mFoxo1-AA/w; hsGal4/+,
(B-blue bars) w; ActGal4/UAS-dPI3K-DN.In Drosophila, PI3K consists of an adaptor subunit, dp60, and
a catalytic subunit, dp110. Unexpectedly, expression of an inhibitory
or "dominant negative" version of dp110 (UAS-dPI3K-DN)[46] under the control of the ActGal4 did not
lead to increased larval wandering (Figure 2B). Expression of this construct also
did not appear to inhibit larval growth, whereas other negative
regulators of insulin signaling do [18].
It is possible that the level of expression of this construct is
not high enough under the control of the ActGal4 driver to have
a complete dominant negative effect.Starved larvae which are developmentally arrested are able to
resume growth upon acquisition of food [17].
We examined if larvae that were expressing dFOXO could resume growth
upon termination of dFOXO expression. To do this we utilized the hsGal4 driver [47]. dFOXO was expressed in the
larvae by heat shock treatment (HST) for 10 minutes every 24 hours.
This treatment was sufficient to inhibit growth while allowing controls
to survive to adulthood with a 48 hour delay in the time to pupation (Figure 2C). When dFOXO expression
was discontinued after 2, 4, and 6 days of HST, developmentally
arrested larvae were able to recover with decreased levels of survival as
time progressed (Figure 2D).
Significant lethality was observed in controls as well suggesting
that low survival rate was partially due to the expression of Gal4,
which can induce apoptosis [48], or the HST itself
(Figure 2D).
Nevertheless, developmental arrest caused by dFOXO is clearly reversible
as these individuals could be returned to their normal path of development.
dFOXO performs an analogous function to C. elegans, Daf-16
The formation of dauer larvae in C. elegans is a developmental
response to nutrient limitation [19].
The dauer larvae provides a temporary defense mechanism allowing the
nematode to persevere until nutrients are available, at which point
development can continue. Interestingly, constitutive activation
of Daf-16 by mutation of its Akt phosphorylation sites to alanine
residues causes obligatory dauer larvae formation[49]. We found a similar result in the Drosophila
larvae using the constitutively active mFoxo1-AA [45]. This construct had an effect similar
to that of dFOXO when expressed under the control of ActGal4 (Figure 2A), and hsGal4 (Figure 2C). Upon removal from
HST, larvae expressing mFoxo1-AA did not resume growth but remained
in a state of developmental arrest until death (Figure 2D). Although a few larvae
did survive to adulthood after 2 days of HST, none of the larvae
were able to continue development after 4, or 6 days of HST (Figure 2D). Out of 450 larvae
examined at all time points, only 10 expressing mFoxo1-AA survived, when
compared to 110 and 180 for larvae expressing dFOXO, and Gal4 alone,
respectively. Presumably this occurs because Akt is unable to deactivate
mFoxo1-AA, allowing it to continue functioning long after expression is
induced. Taken together, this data suggests that dFOXO is evolutionarily
conserved in function, possibly playing a role in the response to
nutritional adversity, as seen in the formation of dauer larvae
in C. elegans.
dFOXO inhibits growth through alterations in cell size
and cell number
Expression of dFOXO in the third instar larvae caused significant
lethality, however, rare flies that did survive were much smaller
than control flies (Figure 3A),
showing a phenotype similar to that caused by mutations in chico [12], dAkt [14] and dInr [6,9].
Expression of dFOXO under the control of the ubiquitous
low level Gal4 drivers, armadillo-Gal4, and hsGal4 (raised
at 25°C with no heat shock) had very little effect on growth (data
not shown). In contrast, increasing expression of dFOXO using
the hsGal4 driver in flies raised at 29°C lead to the development
of small adults, which were approximately half the weight of control
flies (Figures 3B and 3D). Analysis of the
wings of these flies showed that the wing area was reduced by nearly
one third and that this reduction was due to a decrease in both
cell size and cell number (Figures 3C and 3D). SEM analysis of
the eyes revealed reductions in both ommatidia number and ommatidia
area, which reflect cell number and cell size, respectively (Figures 3E and 3F). These results implicate
dFOXO in the control of body size through alterations in cell size
and cell number.
Figure 3
dFOXO reduces growth through alterations in cell size
and cell number (A) Expression of UAS-dFOXO in the third
larval instar produces small flies (left) when compared to controls
(right). w; hsGal4/CyO flies were crossed to w; UAS-dFOXO/UAS-dFOXO flies
and the progeny were heat shocked at 37°C for 4 hours during the
early third instar. (B) Flies of the genotype w; hsGal4/+; UAS-dFOXO/+ (left)
were smaller than w; hsGal4/+ (right) flies when raised
at 29°C. (C) The wings of w; hsGal4/+; UAS-dFOXO/+ flies
raised at 29°C were smaller than control wings (scale bar = 1 mm).
(D) Flies expressing dFOXO (red bars) also showed a significant reduction
in body weight, wing area, cell number, and cell size when compared
to control flies (grey bars) (p = 0.005). (E) Flies expressing dFOXO
had smaller eyes than control flies (scale bar = 150 μm), and (F)
their eyes were reduced in both the number of ommatidia and the
area of the ommatidia (red bars) when compared to controls (grey
bars). Genotypes are; (A-left, B-left, C-top, D-red bars, E-left,
F-red bars) w; hsGal4/+; UAS-dFOXO/+, (A-right, B-right,
C-bottom, D-grey bars, E-right, F-grey bars). w; hs-Gal4/+.
dFOXO reduces growth through alterations in cell size
and cell number (A) Expression of UAS-dFOXO in the third
larval instar produces small flies (left) when compared to controls
(right). w; hsGal4/CyO flies were crossed to w; UAS-dFOXO/UAS-dFOXO flies
and the progeny were heat shocked at 37°C for 4 hours during the
early third instar. (B) Flies of the genotype w; hsGal4/+; UAS-dFOXO/+ (left)
were smaller than w; hsGal4/+ (right) flies when raised
at 29°C. (C) The wings of w; hsGal4/+; UAS-dFOXO/+ flies
raised at 29°C were smaller than control wings (scale bar = 1 mm).
(D) Flies expressing dFOXO (red bars) also showed a significant reduction
in body weight, wing area, cell number, and cell size when compared
to control flies (grey bars) (p = 0.005). (E) Flies expressing dFOXO
had smaller eyes than control flies (scale bar = 150 μm), and (F)
their eyes were reduced in both the number of ommatidia and the
area of the ommatidia (red bars) when compared to controls (grey
bars). Genotypes are; (A-left, B-left, C-top, D-red bars, E-left,
F-red bars) w; hsGal4/+; UAS-dFOXO/+, (A-right, B-right,
C-bottom, D-grey bars, E-right, F-grey bars). w; hs-Gal4/+.
Regulation of FOXO by the insulin signaling pathway
is conserved between mammals and flies
When dFOXO is expressed in the developing eye under the control
of the GMR-Gal4 driver[50],
the eye is smaller, lacking many ommatidia and nearly all of the
mechanosensory bristles (Figure 4E).
The remaining ommatidia are arranged in the typical hexahedral array
and cross sectional analysis revealed that all of the normal photoreceptor
cells are present (Figure 4E,
data not shown). Thus, it appears that dFOXO expression causes
a reduction in the number of cells but does not interfere with cellular
differentiation and the organization of the ommatidia themselves.
We have used this eye phenotype to test for interactions between
dFOXO and other components of the insulin signaling pathway.
Figure 4
Regulation of dFOXO through insulin signaling is conserved
between mammals and flies. The GMR-Gal4 driver was
used to drive the expression of (B) dPI3K-DN, (C) wild type dPI3K,
(D) dAkt, (E) dFOXO, (I) mFoxo1, and (M) mFoxo1-AA, both alone and
in various combinations (F-H, J-L, N-P) as indicated through the
rows and columns in the figure (scale bar = 150 μm). Genotypes are:
(A) w; GMR-Gal4/+, (B) w; UAS-dPI3K-DN/GMR-Gal4,
(C) w; UAS-dPI3K/GMR-Gal4, (D) w; UAS-dAkt/GMR-Gal4,
(E) w; GMR-Gal4/+; UAS-dFOXO/+, (F) w; UAS-dPI3K-DN/GMR-Gal4;
UAS-dFOXO/+, (G) w; UAS-dPI3K/GMR-Gal4; UAS-dFOXO/+,
(H) w; UAS-dAkt/GMR-Gal4; UAS-dFOXO/+ (I) w; GMR-Gal4,
UAS-mFoxo1/+, (J) w; GMR-Gal4, UAS-mFoxo1/UAS-dPI3K-DN,
(K) w; GMR-Gal4, UAS-mFoxo1/UAS-dPI3K, (L) w; GMR-Gal4,
UAS-mFoxo1/UAS-dAkt, (M) w, UAS-mFoxo1-AA/w; GMR-Gal4/+,
(N) w, UAS-mFoxo1-AA/w; GMR-Gal4/UAS-dPI3K-DN, (O) w,
UAS-mFoxo1-AA/w; GMR-Gal4/UAS-dPI3K, (P) w, UAS-mFoxo1-AA/w;
GMR-Gal4/UAS-dAkt.
Expression of dPI3K-DN under the control of GMR-Gal4 leads
to the formation of relatively normal eyes with fewer and smaller
cells[46] (Figure 4B). When dFOXO is co-expressed
in the developing eye with dPI3K-DN the eye is nearly obliterated
(Figure 4F).
In contrast, co-expression of dAkt, and wild type dPI3K with dFOXO
causes nearly complete rescue of the phenotype, restoring the ommatidia
and nearly all of the mechanosensory bristles (Figures 4G and 4H). Thus, diminishing
insulin signaling (through overexpression of dPI3K-DN) allows for
greater activity of dFOXO, and enhancing insulin signaling (through
overexpression of dAkt or dPI3K) leads to inhibition of dFOXO activity.
Similar results were obtained using a MurineFoxo1 (mFoxo1)
construct (Figure 4 I-L), indicating
that the regulatory mechanisms between these two proteins is conserved
and that they are functionally interchangeable.Regulation of dFOXO through insulin signaling is conserved
between mammals and flies. The GMR-Gal4 driver was
used to drive the expression of (B) dPI3K-DN, (C) wild type dPI3K,
(D) dAkt, (E) dFOXO, (I) mFoxo1, and (M) mFoxo1-AA, both alone and
in various combinations (F-H, J-L, N-P) as indicated through the
rows and columns in the figure (scale bar = 150 μm). Genotypes are:
(A) w; GMR-Gal4/+, (B) w; UAS-dPI3K-DN/GMR-Gal4,
(C) w; UAS-dPI3K/GMR-Gal4, (D) w; UAS-dAkt/GMR-Gal4,
(E) w; GMR-Gal4/+; UAS-dFOXO/+, (F) w; UAS-dPI3K-DN/GMR-Gal4;
UAS-dFOXO/+, (G) w; UAS-dPI3K/GMR-Gal4; UAS-dFOXO/+,
(H) w; UAS-dAkt/GMR-Gal4; UAS-dFOXO/+ (I) w; GMR-Gal4,
UAS-mFoxo1/+, (J) w; GMR-Gal4, UAS-mFoxo1/UAS-dPI3K-DN,
(K) w; GMR-Gal4, UAS-mFoxo1/UAS-dPI3K, (L) w; GMR-Gal4,
UAS-mFoxo1/UAS-dAkt, (M) w, UAS-mFoxo1-AA/w; GMR-Gal4/+,
(N) w, UAS-mFoxo1-AA/w; GMR-Gal4/UAS-dPI3K-DN, (O) w,
UAS-mFoxo1-AA/w; GMR-Gal4/UAS-dPI3K, (P) w, UAS-mFoxo1-AA/w;
GMR-Gal4/UAS-dAkt.
Growth effects of dPI3K and dAkt are masked by expression
of mFoxo1-AA
The constitutively active mFoxo1-AA construct [45] was also expressed in the developing
eye. Expression of this construct causes a phenotype similar to
that of dFOXO and mFoxo1, with characteristic lack of ommatidia
and mechanosensory bristles (Figure 4M).
When mFoxo1-AA is co-expressed with dPI3K-DN the eye is nearly obliterated
(Figure 4N),
as seen with dFOXO and mFoxo1 (Figures 4F and 4J).
Co-expression of mFoxo1-AA with dPI3K leads to a partial rescue
of the phenotype, with still an obvious lack of ommatidia and mechanosensory
bristles (Figure 4O).
In contrast, co-expression of mFoxo1-AA with dAkt does not cause
rescue of the ommatidia or mechanosensory bristles (Figure 4P), indicating that
this construct is not responsive to dAkt signaling. The partial rescue
of the dFOXO phenotype by dPI3K appears to be mediated through alterations
in cell size (Figure 5) rather than
cell number, as there is still an obvious lack of ommatidia and
mechanosensory bristles (Figure 4O). This
data indicates that inactivation of dFOXO is required for the full
effects of growth mediated by dPI3K and dAkt.
Figure 5
dFOXO inactivation is essential for dAkt, but not dPI3K,
mediated increases in cell size. Ommatidia area was measured
as a means to determine the effect of FOXO overexpression on cell
size. Expression of dFOXO (bar 2), mFoxo1 (bar 3), and mFoxo1-AA
(bar 4) under the control of GMR-Gal4 causes a significant
decrease in ommatidia area when compared to the expression of Gal4
alone (bar 1). In addition, GMR-Gal4 was used to drive
the expression of dPI3K (bars 5–8), and UAS-dAkt (bars
9–12), either alone (grey bars), or in the presence of UAS-dFOXO (red
bars), UAS-mFoxo1 (light green bars), or UAS-mFoxo1-AA (dark
green bars). Two sided t-tests were preformed to determine statistical
significance (p = 0.001). Genotypes are: (1) w; GMR-Gal4/+,
(2) w; GMR-Gal4/+; UAS-dFOXO/+, (3) w; GMR-Gal4, UAS-mFoxo1/+,
(4) w, UAS-mFoxo1-AA/w; GMR-Gal4/+, (5) w; UAS-dPI3K/GMR-Gal4,
(6) w; UAS-dPI3K/ GMR-Gal4; UAS-dFOXO/+, (7) w; GMR-Gal4,
UAS-mFoxo1/UAS-dPI3K, (8) w, UAS-mFoxo1-AA/w; GMR-Gal4/UAS-dPI3K,
(9) w; UAS-dAkt/GMR-Gal4, (10) w; UAS-dAkt/GMR-Gal4;
UAS-dFOXO/+ (11) w; GMR-Gal4, UAS-mFoxo1/UAS-dAkt (12) w,
UAS-mFoxo1-AA/w; GMR-Gal4/UAS-dAkt.
dFOXO inactivation is essential for dAkt, but not dPI3K,
mediated increases in cell size. Ommatidia area was measured
as a means to determine the effect of FOXO overexpression on cell
size. Expression of dFOXO (bar 2), mFoxo1 (bar 3), and mFoxo1-AA
(bar 4) under the control of GMR-Gal4 causes a significant
decrease in ommatidia area when compared to the expression of Gal4
alone (bar 1). In addition, GMR-Gal4 was used to drive
the expression of dPI3K (bars 5–8), and UAS-dAkt (bars
9–12), either alone (grey bars), or in the presence of UAS-dFOXO (red
bars), UAS-mFoxo1 (light green bars), or UAS-mFoxo1-AA (dark
green bars). Two sided t-tests were preformed to determine statistical
significance (p = 0.001). Genotypes are: (1) w; GMR-Gal4/+,
(2) w; GMR-Gal4/+; UAS-dFOXO/+, (3) w; GMR-Gal4, UAS-mFoxo1/+,
(4) w, UAS-mFoxo1-AA/w; GMR-Gal4/+, (5) w; UAS-dPI3K/GMR-Gal4,
(6) w; UAS-dPI3K/ GMR-Gal4; UAS-dFOXO/+, (7) w; GMR-Gal4,
UAS-mFoxo1/UAS-dPI3K, (8) w, UAS-mFoxo1-AA/w; GMR-Gal4/UAS-dPI3K,
(9) w; UAS-dAkt/GMR-Gal4, (10) w; UAS-dAkt/GMR-Gal4;
UAS-dFOXO/+ (11) w; GMR-Gal4, UAS-mFoxo1/UAS-dAkt (12) w,
UAS-mFoxo1-AA/w; GMR-Gal4/UAS-dAkt.
dPI3K can increase cell size in the presence of constitutively
active Foxo
To examine the effect of dFOXO overexpression on cell size we
measured the area of the ommatidia. Expression of dFOXO, mFoxo1,
and mFoxo1-AA caused a significant reduction in the area of the
ommatidia (p = 0.001) (Figure 5).
Expression of dPI3K caused a significant increase in ommatidia
size over wild type (p = 0.001) (Figure 5).
This result is consistent with previous studies showing that dPI3K
affects cell size in a cell autonomous manner[46]. Co-expression of dFOXO, mFoxo1, and
mFoxo1-AA with dPI3K had no significant effect on the enlarged
ommatidia (p = 0.001) (Figure 5).
Thus, it appears that FOXO proteins have a very minimal effect on
cell size in the presence of high levels of dPI3K. Surprisingly,
this is the case even with the mFoxo1-AA construct, which is only
partially responsive to PI3K signaling [45].
This indicates that the dPI3K mediated increase in cell size can
occur through dAkt independent mechanisms.Expression of dAkt in the developing eye caused a significant
increase in ommatidia size, similar to that seen with dPI3K (p =
0.001) (Figure 5). Co-expression
of dAkt with either dFOXO or mFoxo1, cause a slight, but insignificant decrease
in the size of the enlarged ommatidia (Figure 5). However,
co-expression of dAkt with mFoxo1-AA resulted in ommatidia that
were approximately the same size as the ommatidia in eyes expressing
Gal4 alone (Figure 5), and significantly
smaller than the ommatidia in eyes expressing dAkt alone (p = 0.001)
(Figure 5). This indicates that
the deactivation of FOXO by dAkt is essential for dAkt to induce
an increase in cell size.
dFOXO may reduce cell number through inhibition of the cell
cycle and not apoptosis
The lack of ommatidia and mechanosensory bristles caused by dFOXO
expression suggest a reduction in cell number during eye development
(Figure 6A).
Reduction of cell number can occur through either increased cell death,
or decreased of cell proliferation. The Drosophila inhibitors of
apoptosis, Diap1 and Diap2 (data not shown), and the baculovirus
inhibitor of apoptosis, p35 (Figure 6B),
were unable to rescue the phenotype caused by dFOXO expression.
In addition, acridine orange staining of eye imaginal discs expressing
dFOXO showed no increase in apoptosis when compared to controls
(data not shown). DrosophilaEpidermal Growth Factor Receptor (dEGFR)
signaling acts to protect differentiated cells from death during
eye development [51]. We thought that the
pro-survival effects of dEGFR may be sufficient to suppress the
phenotype caused by dFOXO overexpression. Co-expression of dEGFR
with dFOXO, however, does not rescue the dFOXO phenotype as ommatidia
and bristles are clearly still missing (Figure 6D). Conversely, dFOXO does
not appear to affect the phenotype of dEGFR overexpression as the
general disorganization of the ommatidia appears to be the same
(Figure 6C).
Thus, it appears that these two mechanisms are acting independently.
Taken together, these results suggest that dFOXO overexpression does
not cause cell death during eye development as direct inhibitors
of the apoptotic machinery (p35 and Diap1/2) and a known cell survival
factor (dEGFR) were unable to rescue the dFOXO phenotype.
Figure 6
dFOXO responds to dRas2 signaling, but not to inhibitors
of apoptosis. GMR-Gal4 was used to drive the expression
of UAS-dFOXO (A) alone, and in the presence of (B) UAS-p35,
(D) UAS-dEGFR, (F) UAS-Ras2. UAS-Ras2was
also expressed in combination with UAS-mFoxo1 (G) and UAS-mFoxo1-AA (H).
Scale bars equal 150 μm. Genotypes are: (A) w; GMR-Gal4/+; UAS-dFOXO/+,
(B) w; GMR-Gal4/UAS-p35; UAS-dFOXO/+,
(C) w; GMR-Gal4/UAS-dEGFR, (D) w; GMR-Gal4/UAS-dEGFR; UAS-dFOXO/+,
(E) w; GMR-Gal4/UAS-Ras, (F) w; GMR-Gal4/UAS-Ras2;
UAS-dFOXO/+, (G) w; GMR-Gal4, UAS-mFoxo1/UAS-Ras2,
and (H) w, UAS-mFoxo1-AA/w; GMR-Gal4/ UAS-Ras2.
dFOXO responds to dRas2 signaling, but not to inhibitors
of apoptosis. GMR-Gal4 was used to drive the expression
of UAS-dFOXO (A) alone, and in the presence of (B) UAS-p35,
(D) UAS-dEGFR, (F) UAS-Ras2. UAS-Ras2was
also expressed in combination with UAS-mFoxo1 (G) and UAS-mFoxo1-AA (H).
Scale bars equal 150 μm. Genotypes are: (A) w; GMR-Gal4/+; UAS-dFOXO/+,
(B) w; GMR-Gal4/UAS-p35; UAS-dFOXO/+,
(C) w; GMR-Gal4/UAS-dEGFR, (D) w; GMR-Gal4/UAS-dEGFR; UAS-dFOXO/+,
(E) w; GMR-Gal4/UAS-Ras, (F) w; GMR-Gal4/UAS-Ras2;
UAS-dFOXO/+, (G) w; GMR-Gal4, UAS-mFoxo1/UAS-Ras2,
and (H) w, UAS-mFoxo1-AA/w; GMR-Gal4/ UAS-Ras2.Since inhibition of apoptosis could not rescue the phenotype
caused by dFOXO overexpression in the eye, we examined if activating
the cell cycle could inhibit the phenotype. Expression of the E2F
and Dp transcription factors has been shown to promote cell proliferation
in the wing imaginal disc[4]. Co-expression
of E2F and Dp with dFOXO was not sufficient to rescue the dFOXO
phenotype (data not shown). Overexpression of constitutively active
dRas1 (dRas1V12) has been shown to induce ectopic cell
proliferation[52] and G1/S progression
in the Drosophila wing disc[53,54].
Co-expression of dRas1V12 with dFOXO was lethal, so we
used a constitutively active version of dRas2 (dRas2V14).
Although dRas2 has not been characterized for its role in cell
cycle control, it is possible that it has a similar function to
dRas1. Expression of UAS-dRas2V14 under the control of
GMR-Gal4 led to extreme overgrowth of the eye, lack of ommatidial
organization, and the formation of huge ommatidia (Figure 6E). Co-expression of
dRas2V14 with dFOXO was sufficient to restore many of
the ommatidia and mechanosensory bristles lost through overexpression
of dFOXO alone (Figure 6A and 6F). A similar effect
was observed upon co-expression of dRas2V14 with mFoxo1 (Figure 6G). In contrast, the
loss of ommatidia and bristles seen upon over expression of mFoxo1-AA
was not rescued by dRas2V14 (Figure 6H). This suggests that
dRas2V14 inhibits dFOXO via a dAkt phosphorylation dependent mechanism.
Discussion
For the most part, the genetic mechanisms that control size in
multicellular organisms are not well understood [2].
Recently, components of the insulin signaling pathway have been
shown to regulate body size in Drosophila melanogaster through
alterations in cell size and cell number [1,6]. We have identified
dFOXO as a negative controller of growth and organism size, which
is regulated by components of the Drosophila insulin signaling pathway,
dPI3K and dAkt. Through overexpression studies in the developing
eye, we have shown that dFOXO is regulated by dPI3K and dAkt in
a manner that is consistent with the regulatory mechanisms deduced
through studies in C. elegans and mammalian cell culture.
In addition, overexpression of dFOXO in the larvae reduces larval growth,
phenocopies the effects of nutritional stress, and causes alterations
in feeding behavior. With this in mind, we propose that dFOXO is
involved in the response of Drosophila larvae to nutritional stress.
Conservation of FOXO in Drosophila
The FOXO homologues appear to play an evolutionarily conserved
role in the control of cellular processes under conditions of low
levels of insulin signaling [30,31].
Our experiments provide three lines of evidence supporting the
conservation of this mechanism in Drosophila. First, dFOXO shows
strong sequence homology to Daf-16 and the humanFOXO homologues
(Figure 1B).
One significant characteristic is the high conservation of the three consensus
Akt phosphorylation sites, suggesting that dAkt is most likely able
to phosphorylate dFOXO in vivo, as shown biochemically
with the mammalianFOXO homologues[33-35].
Second, our experiments show that dFOXO and mFoxo1 cause nearly
identical phenotypic responses when overexpressed in the developing
Drosophila eye (Figure 4, 5 and 6).
This suggests that the activity of these proteins is highly conserved
as is observed when the C. elegansFOXO homologue, Daf-16,
is expressed in mammalian cell culture[32].
Third, the phenotypic effects of FOXO overexpression can be modulated by
alterations in the insulin signaling pathway. Reduced insulin signaling
leads to a drastic enhancement of the phenotype that results from
expression of FOXO factors (Figure 4).
In contrast, increased insulin signaling tends to mask these phenotypes,
in a manner that is dependent on the integrity of the Akt phosphorylation
sites (Figures 4 and 5). As a result, we believe that regulation
of FOXO is conserved in Drosophila, and that this will be a very
useful system in elucidating the function of FOXO transcription
factors in a model organism.
Regulation of size by dFOXO
Our results show that ectopic dFOXO expression can mediate reduction
in cell size and cell number (Figures 3, 4, and 5).
However, the mechanisms by which these reductions occur are still
unclear. Net reduction in cell number may occur through decreased
cell proliferation or increased apoptosis. Insulin and other growth
factors that activate PI3K and Akt have been implicated as potent survival
factors in mammalian cell culture [10,11].
They prevent cell death, in part, by inhibition of FOXO factors and
it has been shown that FOXO3a can upregulate expression of the pro-apoptotic
protein Bim[55]. In Drosophila,
reduction of insulin signaling can lead to apoptosis in the developing
embryo [13,14,56,57].
It is possible that this increase in apoptosis is a result of dFOXO activation,
however, when dFOXO is expressed in the developing eye there is
no apparent increase in apoptosis, nor is the phenotype suppressed
by inhibition of caspases, or by co-expression of a known cell
survival factor, dEGFR (unpublished observations, Figure 6). These apparent discrepancies may be
the result of tissue specific differences. In mammalian cell culture,
induction of cell death by FOXO factors seems to be limited to non-transformed haematopoietic
cell lineages [31]. In Drosophila,
loss of dAkt function, inhibition of dPI3K, or overexpression of dPTEN,
all induce cell death in the embryo[13,14].
However, in imaginal disc cells lacking PI3K function, there is no
increase in apoptosis[58]. Thus, the cells
in the embryo and imaginal discs may react differently to reduced
levels of insulin signaling. Although we do not observe induction
of apoptosis upon dFOXO expression, it is possible that increased
levels of dFOXO activity (eg. through dominant negative inhibition
of PI3K) do cause apoptosis.Studies in mammalian cell culture have implicated FOXO factors
in control of the cell cycle through increased expression of the
cyclin dependent kinase inhibitor p27Kip1 [59,60].
It is possible that the reduction of cell number seen upon dFOXO
expression is a result of cell cycle inhibition. Co-expression of
an activated version of DrosophilaRas2 (dRas2V14) was
sufficient to increase cell number in the presence of dFOXO (Figure 6). dRas1 has been shown to induce growth
in Drosophila imaginal discs [52-54] through
activation of dPI3K and the transcription factor dMyc [53]. Although there is very little information
available about dRas2, it is possible that the function of dRas2
overlaps with that of dRas1. Expression of dRas2V14 in
the developing eye does cause a phenotype that suggests overgrowth
of cells (Figure 6E),
and the dRas2V14 interaction with dFOXO appears to be dependent
on dAkt signaling (Figure 6H).
This is not surprising considering that dRas1 [53] and mammalian Ras [61] have been shown to activate PI3K signaling.
Interestingly, increasing the cell cycle through overexpression
of the transcription factors E2F and Dp did not rescue the cell
number deficit seen upon overexpression of dFOXO (unpublished observations).
This suggests the possibility that activation of dFOXO may override
the function of other growth promoting factors, such as dMyc, which mediates
dRas1 induced G1/S progression [53].
Supporting this, we have observed that increased growth as mediated
by dAkt is entirely dependent on its ability to inactivate dFOXO
(Figures 4P and 5). Furthermore, increased growth mediated
by dPI3K appears to be dependent on dFOXO inactivation with respect
to increased cell number, but not cell size (Figures 4O and 5). In humans, inactivation of FOXO factors
may play an important role in tumor suppression by down regulating expression
of D-type cyclins, thus inhibiting cell cycle progression and transformation[62]. It will be interesting to test the
interactions between dFOXO and other cell cycle promoters to determine
the extent of dFOXO dominance over cell proliferation.In addition to its effect on cell number, dFOXO is able to control
cell size (Figures 3 and 5). The ability of dAkt to increase cell
size is dependent on dFOXO inactivation, however, dPI3K does not
need to inactivate dFOXO to increase cell size (Figure 5). The difference between dPI3K and
dAkt might be attributed to greater activity of the UAS-dPI3K transgene.
However, expression of these constructs individually yields very
similar results (Figures 4 and 5) indicating that this is probably not
the case. This suggests that dPI3K may control size through dAkt-independent
mechanisms. One possibility is through the positive growth regulator,
dS6k[63]. dAkt appears
to increase growth through inhibition of a TSC1/TSC2 (tuberous sclerosis)
complex[64,65]. This complex
acts through inhibition of dTOR (target of rampamycin) [66], which promotes growth through activation
of dS6K [67,68]. Although it appears
that dAkt can upregulate growth through dS6K, dS6K activity is not
reduced in larvae lacking dAkt or dPI3K [67].
These results do not necessarily suggest that dPI3K and dAkt can
not activate dS6K, as dS6K levels may be maintained through amino
acid signals [66,68]. dS6K activity
was shown to be dependent on phosphoinositide dependent kinase
(dPDK1) [67], which interacts
genetically with dAkt, dPI3K, dPTEN, and dInr [56,69] Thus,
it is possible that dPI3K can modulate dS6K activity through dPDK1,
independently of dAkt.
Insulin signaling and stress response
Studies in C. elegans indicate that insulin signaling
is a critical mediator of longevity and stress resistance[70,71]. One
of the most well-studied stress responses is the Daf-16 mediated
formation of the dauer larvae under conditions of starvation and/or
crowding. Several lines of evidence indicate that dFOXO may play
a similar role in Drosophila larvae. When Drosophila larvae are
deprived of food prior to 70 hours AEL, they live in a state of
developmental arrest for several days before death. However, when
starved after 70 hours AEL, the larvae are able to develop into
adults that are reduced in size. This alteration in developmental
response has been termed the "70 hour change" and is likely determined
by the minimum size required for a Drosophila larvae to enter pupation[16]. We have mimicked the "70 hour change"
through overexpression of dFOXO at different stages of larval development,
in the presence of ample food (Figures 2 and 3). For example, ubiquitous high level
expression of dFOXO in the early larvae (i.e. before 70 hours AEL)
leads to developmental arrest, whereas heat shock induced expression of
dFOXO during the third instar (i.e. after 70 hours AEL) leads to
the development of small adults. Second, the normal development
of starved larvae can resume upon the acquisition of food. Similarly,
developmental arrest caused by expression of dFOXO prior to the
"70 hour change" can be reversed if dFOXO expression is discontinued
(Figure 2). Developmental arrest
caused by expression of mFoxo1-AA before the "70 hour change" is not
reversible suggesting a constitutive starvation type response as
seen in C. elegans when Daf-16 phosphorylation sites are
mutated[49]. Interestingly,
the reversibility of FOXO induced arrest has also been observed
in mammalian cell culture[72]. Third, under
conditions of poor nutrition or crowding larval development does
not cease, but the larval period is extended and small adults are
produced [15]. We have replicated
this effect through low level expression of dFOXO during the course
of development (Figure 3). Finally,
feeding behavior is drastically altered in larvae expressing dFOXO
(Figure 2), causing them to wander
away from their food. These larvae are often found crawling on the
sides and lids of Petri dishes. This response may provide a selective
advantage in the search for food as seen in C. elegans dauer
larvae, which often crawl up to the highest point possible in hopes
of attaching to passing organisms that could move the larvae to
new locations with better food supply [19].
Taken together, these results suggest that dFOXO activity may act to
promote survival during times of nutritional stress in a manner
that recapitulates the formation of dauer larvae in C. elegans.
It is tempting to speculate that dFOXO plays a role in response
to other forms of stress, as observed with Daf-16[70,71].
MammalianFOXO factors have been implicated in the protective response
to oxidative stress [73-75] and
FOXO factors are upregulated in response to caloric restriction
in rat skeletal muscle [76]. Thus, it is possible
that FOXO factors provide an evolutionarily conserved switch, by
which an organism can alter its developmental program in order
to promote survival under harsh conditions.
Insulin signaling and feeding behavior
Previously, it was observed that activation of insulin signaling
caused larvae to wander away from their food [18]. We have observed a similar effect
through overexpression of dFOXO, which acts in opposition to insulin
signaling. As described previously, it is possible that hyperactivation of
insulin signaling may lead to depletion of the haemolymph by increasing
the cellular uptake of nutrients [18]. This
would lead to increased hunger and cause the larvae to wander in
search of food. Since PI3K activity is lost under conditions of
starvation [18] it stands to reason
that dFOXO would be active under these conditions. Being a transcription
factor, endogenous dFOXO could activate a host of genes under conditions
of starvation leading to a "genetic starvation profile". Indeed
gene expression is drastically altered upon starvation[42]. Thus, dFOXO may induce larval wandering
through expression of a sub-set of genes which are normally active
during starvation, whereas activation of insulin signaling may induce
larval wandering by causing physiological changes that lead to a false
sense of starvation.
Conclusions
We have shown that dFOXO is conserved in sequence and regulatory
mechanisms when compared to homologues from mammals and C. elegans. Drosophila
melanogaster provides a powerful tool for the analysis of genes
in a whole organism. Thus, future studies in this organism should
provide new insights into the biological function of the FOXO transcription
factors. This may have implications to the study of cancer and diseases
related to insulin, such as diabetes and obesity. Our data, taken
together with that of others, suggests that dFOXO plays a protective role
in the developmental response of Drosophila larvae to nutritional
stress. Thus, it is possible that dFOXO plays a functional role
in response to multiple forms of stress. In a world plagued with
massive pollution and hunger it is important that we understand
how our bodies react to starvation and environmental stress.
Methods
Identification and sequence analysis of dFOXO
The humanFOXO4 gene was used to search the NCBI (National
Center for Biotechnology Information) genomic data bank for Drosophila
homologues. Drosophila genomic sequences with high homology to FOXO4 were
identified and used to search the Berkeley Drosophila Genome Project
(BDGP) for homologous cDNAs. This procedure allowed us to identify
the clone, LD05569, which was sub-cloned and sent for sequencing to
Cortec DNA Laboratories, Inc., Kingston, Ontario. Restriction mapping
and sequencing revealed a cDNA of approximately 3.6 kb translating
into a theoretical protein sequence of 463 amino acids (Fig 1B). Note that there
are two other potential start codons that may act as sites for translation
initiation, and are located slightly upstream of the start site
we have identified.
Creation of transgenic Drosophila lines and overexpression
studies
mFoxo1, and mFoxo1-T24A/S253A (AA) clones were
generously provided by Dr. William H. Biggs III [45] and the dFOXO cDNA, LD05569,
was obtained from Research Genetics. The cDNAs were ligated into
the p[PUAST] expression vector for use of the UAS/Gal4 ectopic expression
system [43]. Transgenic flies
were created by injecting p[PUAST]-FOXO constructs into w1118 Drosophila embryos.
Driver lines, GMR-Gal4 [50], heat
shock-Gal4 (hsGal4)[47], and Act5C-Gal4
(ActGal4)[44] were obtained
from the Bloomington stock center, as were the UAS lines UAS-dEGFR, UAS-dRas2, UAS-E2F,
UAS-Dp, UAS-p35, UAS-Diap1, and UAS-Diap2. UAS-dPI3K and UAS-dPI3K-DN (UAS-dp110)
were generously provided by Dr. Sally Leevers. Heat shock treatment
was conducted in a 37°C water bath.
Phenotypic analysis
All experiments were performed at 25°C unless otherwise stated.
For scanning electron micrographs, flies were desiccated overnight
and coated in gold. Ommatidia area was measured using NIHimage 6.2
and each value shown is the mean of 9 measurements, taken from 3
individual eyes. Due to the low survival rate of males expressing dFOXO,
only females were included in the analysis of wings and body weight.
Flies were raised under non-crowded conditions and a minimum of
12 flies were weighed individually to determine average body weight. Wing
area was measured using ImageJ 1.28u, from the National Institute
of Health. Cell size and cell number were calculated as previously
described[63]. A minimum of
10 wings were analyzed per genotype. Two-sided t-tests were performed
to determine significant differences.
Feeding behavior and phenocopy of starvation using ActGal4
The Gal4 driver line w; ActGal4/CyO was crossed to w1118, w;
UAS-dFOXO/UAS-dFOXO, w, UAS-mFoxo1-AA/w, UAS-mFoxo1-AA,
and yw; UAS-dPI3K-DN/UAS-dPI3K-DN. Since the ActGal4 insertion
is not homozygous, we assumed that only half of the hatched larvae
contained the insertion. This assumption was supported by observation
of the adults arising from each cross. For w; ActGal4/CyO X w1118 the
number of adults produced was nearly equal to the number of hatched
embryos, with approximately half bearing the CyO balancer chromosome.
For w; ActGal4/CyO X w; UAS-dFOXO/UAS-dFOXO and w;
ActGal4/CyO X UAS-mFoxo1-AA/w, UAS-mFoxo1-AA only
flies bearing the CyO chromosome survived and the number
of adults was approximately half the number of the total hatched
larvae. Small wandering larvae were observed only for w; ActGal4/CyO X w;
UAS-dFOXO/UAS-dFOXO and w; ActGal4/CyO X UAS-mFoxo1-AA/w,
UAS-mFoxo1-AA, and in these crosses, only the larvae present
in the food were growing. Thus, we assumed that small wandering
larvae were of the genotypes w; ActGal4/+; UAS-dFOXO/+,
and w, UAS-mFoxo1-AA/w; ActGal4/+.For the feeding behavior assay, embryos were collected on apple
juice agar over ~2 hour time periods, counted, and transferred to
a Petri dish with filter paper that was soaked in 20% sucrose in
PBS. In the center of the Petri dish was a small piece of standard
Drosophila food. At 48 hours AEL the number of hatched eggs was
counted to account for unfertilized embryos. At both 48 hours and
72 hours AEL the number of larvae not on the food were counted. The
percent wandering larvae was calculated based on the number of larvae
off the food, the number of hatched eggs, and the assumption that
only half of the total larvae contained the ActGal4 transgene.
The results presented are the average from three separate trials
and statistical significance was determined using a two-sided t-test.
Individual values were taken from analysis of approximately 50 larvae.
Authors' Contributions
JMK conducted all genetic experiments and drafted the manuscript,
as well as playing a partial role in sequence analysis of dFOXO and
the creation of transgenic fly lines. JTD was responsible for the
cloning and sequence analysis of dFOXO. JML participated
in the creation of transgenic fly lines. BES initiated investigation
of the dFOXO gene, and created and initiated characterization
of UAS-dFOXO transgenics, as well as acting as supervisor
and primary investigator.
Authors: Geert J P L Kops; Tobias B Dansen; Paulien E Polderman; Ingrid Saarloos; Karel W A Wirtz; Paul J Coffer; Ting-T Huang; Johannes L Bos; René H Medema; Boudewijn M T Burgering Journal: Nature Date: 2002-09-19 Impact factor: 49.962
Authors: Christen Kerry Mirth; Hui Yuan Tang; Sasha C Makohon-Moore; Samy Salhadar; Rewatee H Gokhale; Raechel D Warner; Takashi Koyama; Lynn M Riddiford; Alexander W Shingleton Journal: Proc Natl Acad Sci U S A Date: 2014-04-28 Impact factor: 11.205
Authors: Anthony J Griswold; Karen T Chang; Alexander P Runko; Melanie A Knight; Kyung-Tai Min Journal: Proc Natl Acad Sci U S A Date: 2008-06-17 Impact factor: 11.205
Authors: Xiangshan Zhao; Lixia Gan; Haiyun Pan; Donghui Kan; Michael Majeski; Stephen A Adam; Terry G Unterman Journal: Biochem J Date: 2004-03-15 Impact factor: 3.857